Safety and Feasibility of TWIICE Rise - Phase 2 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Feasibility of TWIICE Rise - Phase 2 — Stella

Recruiting

Back to Spinal Cord Injuries trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Switzerland

Swiss Paraplegic Centre Nottwil, Nottwil, Canton of Lucerne

Key details

Sponsor

TWIICE

Collaborators

Swiss Paraplegic Research, Nottwil

Enrollment target

~15 participants

Started

July 2023

Primary completion

July 2027

Age range

18 Years – 70 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov